Lyrica (Pregabalin) Linked to Risk of Birth Defects
Researchers have found that pregabalin, a drug used to treat a variety of disorders, may be linked to a multitude of birth defects if used by pregnant women.
The drug is approved under the trade name Lyrica by the Food and Drug Administration in 2012 and is prescribed to treat pain, anxiety, epilepsy and other brain health conditions.
The birth defects that may be linked to the drug are heart defects and structural problems with the nervous system or other organs.
Details About the Pregabalin Study
Information below provided by FOX News:
- During the study, researchers collected information from 164 women in seven countries who took pregabalin during pregnancy and from 656 pregnant women who did not take any anti-seizure drugs.
- Researchers found that women who took pregabalin during the first trimester of pregnancy were three times more likely to give birth to a child with major birth defects than those who did not take anti-seizure drugs.
- Since the study was small and the first of its kind, researchers could not determine a definite cause and effect relationship.